LOGIN
Either etodolac 400mg bid or naproxen 500mg bid effective versus placebo in knee OA treatment
September 2017
Either etodolac 400mg bid or naproxen 500mg bid effective versus placebo in knee OA treatment
Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study
Clin Ther. 1995 Jul-Aug;17(4):656-66Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
254 patients with symptomatic knee osteoarthritis were randomized to receive either etodolac 400mg, naproxen 500mg, or placebo for 4 weeks. Patients were assessed for clinical efficacy using Patients' and Physicians' Global Assessments, and safety was assessed using the incidence of adverse events. Both etodolac and naproxen demonstrated significantly better results for clinical efficacy compared ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.